University researchers have developed novel approaches for the release of therapeutics using engineered bacteria. The invention has the potential to target tumors while maintaining a small in-vivo footprint. This technology has a patent pending.
Country | Type | Number | Dated | Case |
United States Of America | Published Application | 20180148729 | 05/31/2018 | 2015-210 |
Patent Cooperation Treaty | Published Application | 2016164636 | 10/13/2016 | 2015-210 |
bacteria, tumor-targeting, therapeutics